Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-04-07
1997-12-09
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514327, 546 16, 546216, 546217, A61K 31445, C07D21144, C07D21114
Patent
active
056961260
ABSTRACT:
Phenolic prodrug esters of certain 1-(hydroxyphenyl)-2-piperidino-1-alkanol derivatives, which are useful in the treatment of stroke, traumatic head injury and CNS degenerative disease; and intermediates useful in their synthesis.
REFERENCES:
patent: 4690931 (1987-09-01), Wick et al.
patent: 5185343 (1993-02-01), Chenard
patent: 5272160 (1993-12-01), Chenard
patent: 5338754 (1994-08-01), Chenard
patent: 5391742 (1995-02-01), Chenard
Chemical Abstracts vol.99,No.17,abst.no.139,786y,Oct.24,1983.
Chemical Abstracts,vol.101,No.23,abst.no.210,992e,Dec.3,1984.
Benson Gregg C.
Pfizer Inc.
Richardson Peter C.
Ronau Robert T.
Rotman Alan L.
LandOfFree
Prodrug esters of phenolic 2-piperidino-1-alkanols does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prodrug esters of phenolic 2-piperidino-1-alkanols, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prodrug esters of phenolic 2-piperidino-1-alkanols will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1607915